[HTML] mdpi.com

[HTML][HTML] Cannabinoids reduce extracellular vesicle release from HIV-1 infected myeloid cells and inhibit viral transcription

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - mdpi.com
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …
被引用次数：14 相关文章

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - search.proquest.com
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …
[PDF] mdpi.com

[PDF][PDF] Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription. Cells 2022, 11, 723

C DeMarino, M Cowen, P Khatkar, B Cotto… - 2022 - mdpi.com
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

C DeMarino, M Cowen, P Khatkar, B Cotto… - 2022 - agris.fao.org
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

C DeMarino, M Cowen, P Khatkar… - Faculty …, 2022 - scholarshare.temple.edu
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …
[HTML] nih.gov

[HTML][HTML] Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - ncbi.nlm.nih.gov
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - pubmed.ncbi.nlm.nih.gov
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription.

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells (2073 …, 2022 - search.ebscohost.com
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription.

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - europepmc.org
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription.

C DeMarino, M Cowen, P Khatkar, B Cotto… - Cells, 2022 - europepmc.org
Of the 37.9 million individuals infected with human immunodeficiency virus type 1 (HIV-1),
approximately 50% exhibit HIV-associated neurocognitive disorders (HAND). We and others …